Cogent Biosciences, Inc. earns a Strong Buy rating due to positive phase 3 PEAK results for bezuclastinib + Sunitinib. Read ...

Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the 15 stocks set to explode in 2026. On November 7, 2025, Summit ...

The findings came from analyses of two national cancer registries. ILC accounts for about 10% of all newly diagnosed breast ...

Older fathers’ sperm carry more harmful mutations, raising children’s genetic risks. Discover how age impacts DNA and ...

This trial represents the first major advancement in second-line GIST treatment in over two decades, potentially transforming the therapeutic landscape. Cogent Biosciences announced positive results ...

A flu strain that emerged over the summer is causing "unprecedented" outbreaks in Japan, as well as in Canada and the U.K.

Effective management of inherited retinal diseases requires a comprehensive approach to diagnosis and treatment, according to ...

SITC abstracts highlight updated immunogenicity results from the Phase 2 AMPLIFY-7P trial of ELI-002 7P and preclinical data on the use of ...

Experts warn the UK could see its worst flu season in a decade after the virus appears to have changed 'more than expected' ...